These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12620078)

  • 1. Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines.
    Kym PR; Kort ME; Coghlan MJ; Moore JL; Tang R; Ratajczyk JD; Larson DP; Elmore SW; Pratt JK; Stashko MA; Falls HD; Lin CW; Nakane M; Miller L; Tyree CM; Miner JN; Jacobson PB; Wilcox DM; Nguyen P; Lane BC
    J Med Chem; 2003 Mar; 46(6):1016-30. PubMed ID: 12620078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal selective glucocorticoid modulators: the effect of C-5 alkyl substitution on the transcriptional activation/repression profile of 2,5-dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines.
    Elmore SW; Coghlan MJ; Anderson DD; Pratt JK; Green BE; Wang AX; Stashko MA; Lin CW; Tyree CM; Miner JN; Jacobson PB; Wilcox DM; Lane BC
    J Med Chem; 2001 Dec; 44(25):4481-91. PubMed ID: 11728194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of nonsteroidal glucocorticoid receptor ligands based on 6-indole-1,2,3,4-tetrahydroquinolines.
    Roach SL; Higuchi RI; Adams ME; Liu Y; Karanewsky DS; Marschke KB; Mais DE; Miner JN; Zhi L
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3504-8. PubMed ID: 18513967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activity.
    Ali A; Thompson CF; Balkovec JM; Graham DW; Hammond ML; Quraishi N; Tata JR; Einstein M; Ge L; Harris G; Kelly TM; Mazur P; Pandit S; Santoro J; Sitlani A; Wang C; Williamson J; Miller DK; Thompson CM; Zaller DM; Forrest MJ; Carballo-Jane E; Luell S
    J Med Chem; 2004 May; 47(10):2441-52. PubMed ID: 15115388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826).
    Weinstein DS; Gong H; Doweyko AM; Cunningham M; Habte S; Wang JH; Holloway DA; Burke C; Gao L; Guarino V; Carman J; Somerville JE; Shuster D; Salter-Cid L; Dodd JH; Nadler SG; Barrish JC
    J Med Chem; 2011 Oct; 54(20):7318-33. PubMed ID: 21899328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and characterization of nonsteroidal glucocorticoid receptor modulators for multiple myeloma.
    Hudson AR; Roach SL; Higuchi RI; Phillips DP; Bissonnette RP; Lamph WW; Yen J; Li Y; Adams ME; Valdez LJ; Vassar A; Cuervo C; Kallel EA; Gharbaoui CJ; Mais DE; Miner JN; Marschke KB; Rungta D; Negro-Vilar A; Zhi L
    J Med Chem; 2007 Sep; 50(19):4699-709. PubMed ID: 17705362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of novel nonsteroidal dissociating glucocorticoid receptor ligands.
    Shah N; Scanlan TS
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5199-203. PubMed ID: 15380227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of non-steroidal ligands for the glucocorticoid receptor: selective quinoline derivatives with prednisolone-equivalent functional activity.
    Coghlan MJ; Kym PR; Elmore SW; Wang AX; Luly JR; Wilcox D; Stashko M; Lin CW; Miner J; Tyree C; Nakane M; Jacobson P; Lane BC
    J Med Chem; 2001 Aug; 44(18):2879-85. PubMed ID: 11520196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal human progesterone receptor agonists.
    Zhi L; Tegley CM; Kallel EA; Marschke KB; Mais DE; Gottardis MM; Jones TK
    J Med Chem; 1998 Jan; 41(3):291-302. PubMed ID: 9464360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of novel 2-thiophen-5-yl-3H-quinazolin-4-one analogues as inhibitors of transcription factors NF-kappaB and AP-1 mediated transcriptional activation: Their possible utilization as anti-inflammatory and anti-cancer agents.
    Giri RS; Thaker HM; Giordano T; Williams J; Rogers D; Vasu KK; Sudarsanam V
    Bioorg Med Chem; 2010 Apr; 18(7):2796-808. PubMed ID: 20335039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsteroidal glucocorticoid agonists: tetrahydronaphthalenes with alternative steroidal A-ring mimetics possessing dissociated (transrepression/transactivation) efficacy selectivity.
    Biggadike K; Boudjelal M; Clackers M; Coe DM; Demaine DA; Hardy GW; Humphreys D; Inglis GG; Johnston MJ; Jones HT; House D; Loiseau R; Needham D; Skone PA; Uings I; Veitch G; Weingarten GG; McLay IM; Macdonald SJ
    J Med Chem; 2007 Dec; 50(26):6519-34. PubMed ID: 18038970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and SAR study of novel dihydroquinoline containing glucocorticoid receptor ligands.
    Takahashi H; Bekkali Y; Capolino AJ; Gilmore T; Goldrick SE; Nelson RM; Terenzio D; Wang J; Zuvela-Jelaska L; Proudfoot J; Nabozny G; Thomson D
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1549-52. PubMed ID: 16386422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. trans-Activation and repression properties of the novel nonsteroid glucocorticoid receptor ligand 2,5-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and its four stereoisomers.
    Lin CW; Nakane M; Stashko M; Falls D; Kuk J; Miller L; Huang R; Tyree C; Miner JN; Rosen J; Kym PR; Coghlan MJ; Carter G; Lane BC
    Mol Pharmacol; 2002 Aug; 62(2):297-303. PubMed ID: 12130681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulators.
    Zhi L; Tegley CM; Pio B; Edwards JP; Motamedi M; Jones TK; Marschke KB; Mais DE; Risek B; Schrader WT
    J Med Chem; 2003 Sep; 46(19):4104-12. PubMed ID: 12954062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociated nonsteroidal glucocorticoid receptor modulators; discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series.
    Barker M; Clackers M; Copley R; Demaine DA; Humphreys D; Inglis GG; Johnston MJ; Jones HT; Haase MV; House D; Loiseau R; Nisbet L; Pacquet F; Skone PA; Shanahan SE; Tape D; Vinader VM; Washington M; Uings I; Upton R; McLay IM; Macdonald SJ
    J Med Chem; 2006 Jul; 49(14):4216-31. PubMed ID: 16821781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
    Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
    J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents.
    Edwards JP; West SJ; Marschke KB; Mais DE; Gottardis MM; Jones TK
    J Med Chem; 1998 Jan; 41(3):303-10. PubMed ID: 9464361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
    Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
    Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J
    J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a new class of selective nonsteroidal progesterone receptor agonists.
    Dong Y; Roberge JY; Wang Z; Wang X; Tamasi J; Dell V; Golla R; Corte JR; Liu Y; Fang T; Anthony MN; Schnur DM; Agler ML; Dickson JK; Lawrence RM; Prack MM; Seethala R; Feyen JH
    Steroids; 2004 Mar; 69(3):201-17. PubMed ID: 15072922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.